| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/24/2009 | US20090238814 Compositions and methods for treating hypophosphatasia |
| 09/24/2009 | US20090238806 Treatment of intervertebral disc degeneration |
| 09/24/2009 | US20090238763 High penetration compositions and uses thereof |
| 09/24/2009 | US20090238762 Method for treating joint damage |
| 09/24/2009 | CA2719147A1 Treatment of intervertebral disc degeneration |
| 09/24/2009 | CA2719134A1 Treatment with opioid antagonists and mtor inhibitors |
| 09/24/2009 | CA2718966A1 Anti-inflammatory drug delivery system |
| 09/24/2009 | CA2717954A1 Cyclopenta[g]quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia |
| 09/24/2009 | CA2717459A1 Preparation of a pharmaceutical composition for increasing bone mineral density |
| 09/24/2009 | CA2710811A1 N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof |
| 09/23/2009 | EP2103607A1 1-phenyl 1-thio-d-glucitol derivative |
| 09/23/2009 | EP2102226A1 Macrolide compounds endowed with antiinflammatory activity |
| 09/23/2009 | EP2102219A1 Ibandronate sodium propylene glycol solvate and processes for the preparation thereof |
| 09/23/2009 | EP2101818A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
| 09/23/2009 | EP2101810A2 Chymosin for the prevention and treatment of gastrointestinal disorders |
| 09/23/2009 | EP2101765A1 Use of epothilones in the treatment of osteoporosis and related diseases |
| 09/23/2009 | EP2101751A1 Benzamide derivatives as ep4 receptor agonists |
| 09/23/2009 | EP1768748B1 Compositions comprising strontium and vitamin d and uses thereof |
| 09/23/2009 | EP1542528B1 A method of treatment and prophylaxis |
| 09/23/2009 | EP1482928B1 Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 09/23/2009 | EP1420827B1 5-cnac as oral delivery agent for parathyroid hormone fragments |
| 09/23/2009 | EP1416966B1 Methods for treating joint inflammation, pain, and loss of mobility |
| 09/23/2009 | EP1380293A9 Bone metabolism improving agents |
| 09/23/2009 | EP1377288B1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and use |
| 09/23/2009 | EP1282684B1 Chondroitin synthase gene and methods of making and using same |
| 09/23/2009 | CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 09/23/2009 | CN101537182A Combination comprising an HMG CoA reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 09/23/2009 | CN101537170A Compound for preventing osteoporosis and osteoarthrosis |
| 09/23/2009 | CN101537168A Traditional Chinese medicine composition for treatment of cervical spondylopathy and osteoarticular diseases and preparation method thereof |
| 09/23/2009 | CN101537127A Raw bone meal plaster |
| 09/23/2009 | CN101537105A Chinese medicinal preparation for treating hyperosteogeny |
| 09/23/2009 | CN101537103A Dioscorea nipponica effective components for treating acute gouty arthritis and extracting method thereof |
| 09/23/2009 | CN101537093A Chinese traditional medicine for preventing and curing osteoporosis and preparation method thereof |
| 09/23/2009 | CN101537090A Pharmaceutical composition for treating lumbar intervertebral disc protrusion, preparation method and use thereof |
| 09/23/2009 | CN101537080A Pine needle health-care medicinal liquor with efficacy of dispersing pathogenic wind and removing dampness and preparation method thereof |
| 09/23/2009 | CN101537078A Chinese medicinal preparation for treating syringomyelia |
| 09/23/2009 | CN101537077A Chinese medicinal mixed tincture |
| 09/23/2009 | CN101537050A Health product capable of enhancing bone density and immune function, and preparation method and applications thereof |
| 09/23/2009 | CN101537016A Compound microcapsule preparation containing cartilage cells of epiphyseal plate, preparation method and application thereof |
| 09/23/2009 | CN101537003A Application of 7,3'-dimethoxy hesperetin in preparation of anti-inflammatory immune medicaments |
| 09/23/2009 | CN101537002A Diacerein composition with good leaching property, and preparation and use thereof |
| 09/23/2009 | CN101536993A Vitamin D3 microcapsule and preparation method thereof |
| 09/23/2009 | CN101536990A Colchicines gastric floating sustained-release tablet and method for preparing same |
| 09/23/2009 | CN101536859A Traditional Chinese medicine health-care pillow and preparation method thereof |
| 09/23/2009 | CN101536857A Healthcare pillow for treating periarthritis humeroscapularis and cervical spondylosis |
| 09/22/2009 | US7592455 potent and selective inhibitors of p38 kinase, especially p38 alpha , p38 beta and p38 beta 2; immune or inflammatory disorders; Ethyl 3-(benzylamino)-6-oxo-7-phenyl-6,7-dihydrothieno[2,3-b]pyridine-2-carboxylate |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | US7592339 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/22/2009 | US7592010 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 09/22/2009 | US7591949 Method for the improvement of transport across adaptable semi-permeable barriers |
| 09/22/2009 | CA2454584C Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient |
| 09/22/2009 | CA2402121C Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 09/22/2009 | CA2397554C Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
| 09/17/2009 | WO2009114623A2 Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same |
| 09/17/2009 | WO2009114535A2 Bone paste composition |
| 09/17/2009 | WO2009114462A2 Local delivery of chemotherapeutic agents to skeletal metastases |
| 09/17/2009 | WO2009113743A1 Polyethylene glycolated lactoferrin complex and method of producing the same |
| 09/17/2009 | WO2009113512A1 Socs3 expression promoter, drug and food containing the same and method of promoting the expression of socs3 |
| 09/17/2009 | WO2009113423A1 Bicyclic pyrrole compound |
| 09/17/2009 | WO2009113320A1 Mmp inhibitor |
| 09/17/2009 | WO2009113083A1 A monoclonal antibody and a method thereof |
| 09/17/2009 | WO2009112839A1 Compounds |
| 09/17/2009 | WO2009112826A1 Furo [3, 2-b] pyrr0l-3-0nes as cathepsin s inhibitors |
| 09/17/2009 | WO2009112652A1 2-benzoylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112651A1 Imidazo[1,2-a]pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
| 09/17/2009 | WO2009112473A1 Novel compounds |
| 09/17/2009 | WO2009112439A1 4-aryl-2-anilino-pyrimidines as plk kinase inhibitors |
| 09/17/2009 | WO2009111948A1 The salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione or its derivatives, their polymorphs, preparation methods and uses thereof |
| 09/17/2009 | WO2003007876A3 N-fatty acid-amino acid conjugates and therapeutic uses |
| 09/17/2009 | US20090233999 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 09/17/2009 | US20090233906 Imidazoazepinone compounds |
| 09/17/2009 | US20090233880 Equol production accelerating composition |
| 09/17/2009 | US20090233813 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors |
| 09/17/2009 | US20090232940 Process for producing 1,4-dihydoxy-2-naphthoic acid |
| 09/17/2009 | US20090232809 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/17/2009 | US20090232804 Humanized antibodies specific for von willebrand factor |
| 09/17/2009 | US20090232803 Antibodies to human il-1beta |
| 09/17/2009 | US20090232802 Compositions and methods for the treatment of natural killer cell related diseases |
| 09/17/2009 | CA2718252A1 Bicyclic pyrrole compound |
| 09/17/2009 | CA2718153A1 Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same |
| 09/17/2009 | CA2717495A1 Fullerene therapies for inflammation |
| 09/17/2009 | CA2716919A1 An anti-cd6 monoclonal antibody and use thereof |
| 09/17/2009 | CA2716079A1 4-aryl-2-anilino-pyrimidines as plk kinase inhibitors |
| 09/17/2009 | CA2710801A1 2-benzoyl-imidazo(1,2-.alpha) pyridine derivatives, their preparation and their therapeutic application |
| 09/17/2009 | CA2710797A1 Imidazo[1,2-.alpha.]pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
| 09/16/2009 | EP2100876A2 New compounds for the inhibition of rotamases and use thereof |
| 09/16/2009 | EP2100617A1 Methods of modulating CD200 receptors |
| 09/16/2009 | EP2099815A2 Novel amides acting on the adenosine receptors |
| 09/16/2009 | EP2099798A1 Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases |
| 09/16/2009 | EP2099439A2 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 09/16/2009 | EP1523471B1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 09/16/2009 | EP1487807B1 Cyano-pyrrolidines as DPP-IV inhibitors |
| 09/16/2009 | EP1438583B1 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 09/16/2009 | EP1414825B9 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/16/2009 | EP1363629B1 Kappa opioid receptor ligands |
| 09/16/2009 | EP1283834B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/16/2009 | CN101531704A Peptide-based compounds |
| 09/16/2009 | CN101531696A Application of steroid saponin terpenoids and derivatives thereof in preparing medicine for treating purine metabolic disturbance diseases |
| 09/16/2009 | CN101531688A Glucosamine sulfate calcium salt and preparation method thereof |
| 09/16/2009 | CN101531681A High-purity minodronic acid and preparation method thereof |